Title : A novel member of the glycosyltransferase family,
beta 3 Gn-T2 , highly downregulated in invasive human bladder transitional cell carcinomas
Abstract :
- Differential display reverse transcription (DDRT)-polymerase chain reaction (PCR) was used to compare the transcriptomes of invasive and noninvasive fresh human bladder transitional cell carcinomas
- A differentially expressed novel gene sharing structural similarity with the human beta 3-galactosyltransferase family, beta-1,3-N-acetylglucosaminyltransferase-T2 ( beta 3Gn-T2 ), was identified
- The full-length beta 3Gn-T2 cDNA, containing a complete open reading frame of 1193 bp, was cloned and sequenced
- beta 3Gn-T2 exhibited 29-41% homology to the multigene beta 3-galactosyltransferase family
- Expression of the full-length beta 3Gn-T2 cDNA in an in vitro coupled transcription/translation assay yielded a primary translation product with an apparent Mr of 46 kDa, which is in agreement with the predicted 397-amino-acid protein encoded by beta 3Gn-T2
- Multiple peptide alignment showed several sequence motifs corresponding to putative catalytic domains that are conserved throughout all members of the beta 3-galactosyltransferase family, namely, a type II transmembrane domain , a conserved DxD motif , an N-glycosylation site , and five conserved cysteins
- By RT-PCR strong downregulation of beta 3Gn-T2 expression was noted in invasive human bladder transitional cell carcinomas (16 fresh biopsy samples: grade III, T2-T4) compared with their noninvasive counterparts (15 fresh biopsies: grade II, Ta), suggesting that beta 3Gn-T2 may be involved in cancer progression
Output (sent_index, trigger,
protein,
sugar,
site):
- 6. N-glycosylation, , -, -, site
Output(Part-Of) (sent_index,
protein,
site):
*Output_Site_Fusion* (sent_index,
protein,
sugar,
site):